• About Us
  • Corporate Profile
  • Management Team
  • Board of Directors
  • Scientific Advisory Board
  • Respiratory and Acute Care Advisory Board
  • Cardiovascular Advisory Board
  • Immunology Advisory Board
  • Investors
• Products
• Research
  • sPLA2 - What is it?
  • Respiratory and Acute Care Program
  • sPLA2 in SCD
  • IMPACTS Trial Site
  • Scientific Advisory Board
  • Cardiovascular Program
  • sPLA2 in CVD
  • FRANCIS Trial Site
  • PLASMA Trial Site
  • PLASMA 2 Trial Site
  • Scientific Advisory Board
  • Immunology Program
  • A-623 in SLE and Autoimmune Diseases
  • Scientific Advisory Board
  • Preclinical Programs
  • Glossary
  • References
• News & Media
• Careers
• Contact Us

<< Return to Board of Directors

Annette Bianchi‚ Director

Ms. Bianchi, Managing Director at VantagePoint Venture Partners brings 20 years of venture capital experience and significant expertise in all areas of healthcare investing‚ including medical devices‚ biotechnology and healthcare information technology and services. She began her career in venture capital in 1985 as an associate with Burr‚ Egan‚ Deleage & Company and became a General Partner of that firm in 1988. In 1992‚ Annette joined Weiss‚ Peck & Greer Venture Partners as a General Partner of their healthcare practice. In 1999‚ she became a Managing Director at Pacific Venture Group‚ a dedicated healthcare fund. Ms. Bianchi is a graduate of University of Pennsylvania (BSE and MSE in Biomedical Engineering) and The Wharton School (MBA).